Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2025-12-24 @ 2:51 PM
NCT ID:
NCT06273059
Eligibility Criteria:
Inclusion Criteria:
* Diabetic patients
* Diabetic patient fulfilling criteria from Indonesian Endocrinology Association (PERKENI) 2021 guidelines:
* Fasting blood glucose 126 mg/dL
* 2-hour post oral glucose blood glucose/oral glucose tolerance test 200 mg/dL
* HbA1c 6.5%
* Random blood glucose 200 mg/dL with classic symptoms or hyperglycemic crisis.
* Patients aged 8-40 years old when diagnosed with diabetes mellitus
* Registered in Dr. Cipto Mangunkusumo National General Hospital and satellite hospitals
* Willing to participate in the study with proof of informed consent agreement
Exclusion Criteria:
* Subject is experiencing severe illness
Healthy controls Inclusion criteria
* Aged 8-40 years old
* Fulfilling criteria of normal blood glucose levels according to Indonesian Endocrinology Association (PERKENI) 2021 guidelines:
* Fasting blood glucose 100 mg/dL
* 2-hour post oral glucose blood glucose/oral glucose tolerance test 140 mg/dL
* HbA1c 5.7% Exclusion criteria
* Subject is unwilling to participate in the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
40 Years
Study:
NCT06273059
Study Brief:
Protocol Section:
NCT06273059